Fractyl Health director granted 22,500 stock options

FRACTYL HEALTH, INC. director Kelly Ann Barnes received a grant of stock options covering 22,500 shares of common stock as compensation for her board service.

Rhea-AI Filing Summary

FRACTYL HEALTH, INC. director Kelly Ann Barnes received a grant of stock options covering 22,500 shares of common stock as compensation for her board service. The options have an exercise price of $0.7318 per share and expire on June 9, 2036.

According to the terms, the award will vest in a single installment on the earlier of the next annual meeting of stockholders or the first anniversary of the grant, in each case subject to her continued service as a non-employee director. Following this grant, she holds 22,500 options directly.

Insider Trade Summary

Grant/Award: 22,500 shares

Grant/Award 1 txn

Insider Barnes Kelly Ann

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	22,500	$0.00	$0.00

Holdings After Transaction: Stock Option — 22,500 contracts (Direct)

Footnotes (1)

1. F1. The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date.

Key Figures

Option grant size: 22,500 options Exercise price: $0.7318 per share Expiration date: June 9, 2036 +2 more

5 metrics

Option grant size 22,500 options Stock option grant to director on June 10, 2026

Exercise price $0.7318 per share Conversion or exercise price of stock option

Expiration date June 9, 2036 Option expiration for director grant

Underlying shares 22,500 shares Common stock underlying the option grant

Holdings after grant 22,500 options Total options held directly after transaction

Key Terms

stock option, non-employee director compensation policy, annual meeting of stockholders, vesting date, +1 more

5 terms

stock option financial

"The stock option was awarded as compensation for the Reporting Person's service"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

non-employee director compensation policy financial

"pursuant to the Issuer's non-employee director compensation policy"

annual meeting of stockholders financial

"on the earlier of (i) the date of the next annual meeting of stockholders"

vesting date financial

"through the vesting date"

underlying security financial

"underlying security title: Common Stock, underlying security shares: 22500.0000"

FAQ

What did FRACTYL HEALTH (GUTS) director Kelly Ann Barnes report on this Form 4?

Kelly Ann Barnes reported receiving a grant of stock options for 22,500 shares of FRACTYL HEALTH common stock. The award is compensation for her non-employee director service and does not represent an open-market stock purchase or sale.

What are the key terms of Kelly Ann Barnes’s new stock option grant at FRACTYL HEALTH (GUTS)?

The stock option covers 22,500 underlying common shares with an exercise price of $0.7318 per share. It expires on June 9, 2036, giving long-dated potential equity exposure tied to her continued service on the board.

How and when do Kelly Ann Barnes’s FRACTYL HEALTH (GUTS) options vest?

The options vest in a single installment on the earlier of the next annual meeting of stockholders or the first anniversary of the grant date. Vesting is conditioned on her continued service as a non-employee director through that vesting date.

Is the FRACTYL HEALTH (GUTS) Form 4 transaction a market purchase or sale of shares?

No, the Form 4 reports a compensatory stock option grant, not a market trade. The options were awarded under the company’s non-employee director compensation policy rather than being bought or sold on the open market.

How many FRACTYL HEALTH (GUTS) options does Kelly Ann Barnes hold after this grant?

After this reported transaction, Kelly Ann Barnes holds 22,500 stock options directly. These options are all from the newly granted award and relate to the underlying common shares described in the Form 4.

What policy governs Kelly Ann Barnes’s stock option grant at FRACTYL HEALTH (GUTS)?

The stock option was granted under FRACTYL HEALTH’s non-employee director compensation policy. This policy provides equity awards to outside directors as part of their overall compensation for serving on the company’s board.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/11/2026 - 05:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Barnes Kelly Ann

(Last) (First) (Middle)

3 VAN DE GRAAFF DRIVE

SUITE 200

(Street)

BURLINGTON MASSACHUSETTS 01803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
FRACTYL HEALTH, INC. [ GUTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$0.7318	06/10/2026		A		22,500		(1)	06/09/2036	Common Stock	22,500	$0	22,500	D

Explanation of Responses:

1. The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date.

	/s/ Harith Rajagopalan, M.D., Ph.D., Attorney-in-fact	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)